Academy How to trade Pfizer stocks

Pfizer stocks - price, description, and characteristics

Pfizer Inc. is a multinational pharmaceutical company with a focus on disease prevention as well as the development of treatments and cures. The bulk of the company's income comes from the production and sale of biopharmaceutical goods. The therapeutic areas of internal medicine, cancer, hospitals, vaccines, inflammation, and immunology, as well as uncommon diseases, make up the business of Pfizer.

Charles Pfizer and Charles Erhart established Charles Pfizer & Co. in Brooklyn, New York, in 1849, which is where the business got its start.

The business grew in the late 1800s and early 1900s but remained privately owned until it first released shares of its common stock to the general public in June 1942. In the 1940s, it was the first company to mass-manufacture penicillin, and by the early 1970s, its annual revenues had surpassed $1 billion.

With a market valuation of $251.3 billion as of November 3, 2021, Pfizer has grown to be one of the largest pharmaceutical firms in the world. The Pfizer corporate office is in New York City.

The corporation that makes pharmaceuticals now has Albert Bourla as its CEO.
Pfizer works in the biotechnology and pharmaceutical sectors and is categorized as a part of the S&P 500 healthcare category.

The main rivals of Pfizer are Roche Holding AG (RHHBY), located in Switzerland, Merck & Co. Inc. (MRK), and Eli Lilly and Co. (LLY). In its fiscal year 2021, Pfizer recorded adjusted net income attributable to its common shareholders of $25.2 billion on $81.3 billion in yearly sales (FY).

Pfizer stock performance

Pfizer (PFE) stock has been a long-time gainer over the years. The price really took off in the 1990s until the early 2000s’. If you invested in Pfizer in the '80s’, you would see your account grow over twenty-fold by the end of the 90’, followed by a steady decline until 2009.

You could say this stock kept its trend for years as the price started to gain again to this day, making its investors, again, multiple times what they invested.

Pfizer's market capitalization is $247.44 billion. which makes it now the 28th most valuable corporation in the world.
Pfizer also regularly distributes a $0.39 per share cash dividend, which makes long-time holding more attractive.

The company has been in a slower long-term uptrend since 2016 until the COVID-19 global pandemic hit when the stock took off. Pfizer is one of the COVID-19 vaccine manufacturers, which we can see is reflected in the price as well.

The turbulent stock market has been also fueled by the Fed’s ultra-loose monetary policy, which we can see as spikes in the price chart.

Trading Pfizer (PFE) with Purple Trading

To start your Pfizer CFDs trading, first, you need to locate the ticker PFE on our Purple Trading MetaTrader 4 platform. To open a trade, either double-click or press the new order button, and the following window will pop up.

Lot value calculation

When you open our MetaTrader 4 platform and click on the PFE ticker, you'll observe that the minimal volume for trading Pfizer CFDs is one lot (1.0). If you trade one lot, you will gain or lose 1 USD for each 1 USD the stock makes as you are buying at a 1:1 ratio (1 lot equals 1 share). For example, you buy 5 lots at 50 USD, and PFE goes to 60 USD. Your total profit will be 50 USD (calculated as 10 USD (1000 cents) movement * number of lots/shares per the move). The same logic applies to calculating your profit or loss when entering a short position.

Keep in mind that PFE is quoted in US dollars, therefore if your account is in EUR or another currency, your profit or loss must be converted to EUR at the current exchange rate.

You can trade at the current market price (market execution) or utilize pending orders, (limit and stop orders). You can initiate the trade without the stop-loss and take-profit orders now and add them afterward.